Stay updated on Oral PHA-022121 Dose-ranging Clinical Trial
Sign up to get notified when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.

Latest updates to the Oral PHA-022121 Dose-ranging Clinical Trial page
- Check7 days agoChange DetectedAdded Revision: v3.3.3 to the site release notes/footer and removed HHS Vulnerability Disclosure and Revision: v3.3.2. These updates do not affect the trial record content or its history.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page's revision history now includes a new entry for Revision v3.3.2. The entry for Revision v3.2.0 has been removed.SummaryDifference0.1%

- Check43 days agoChange DetectedThe government funding/operating status notice displayed on the page has been removed.SummaryDifference0.5%

- Check57 days agoChange DetectedA new version entry appears in the Record History and minor UI adjustments are visible; core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check86 days agoChange DetectedAdded a prominent operating-status notice and a new software version (v3.2.0); removed the old version label (v3.1.0).SummaryDifference10%

- Check93 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.2%

Stay in the know with updates to Oral PHA-022121 Dose-ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.